Overview

Study of Paxil Use in Menopausal Women

Status:
Completed

Trial end date:
2006-09-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy, safety, and tolerability of Paroxetine treatment in perimenopausal and postmenopausal women who present with menopause-related symptoms after discontinuing hormone therapy (HT), in the presence or absence of concomitant symptoms of depression or anxiety.

Phase:

Phase 4

Details

Lead Sponsor:

Massachusetts General Hospital

Collaborator:

GlaxoSmithKline

Treatments:

Paroxetine